Loading news...
Loading news...
RVAC Medicines raised $140M Series B venture round, led by Wei Fu.
This funding round does not have an about section yet.
| Investor | Firm Type | Partner |
|---|
C-Bridge CapitalLEAD | Venture Capital | — |
| Corporate Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$140M
Top Valuation
-
RVAC Medicines raised $140M in a Series B round.
The round was announced on 04/27/22.
The round was led by Wei Fu.